Q. Vincent, M. Ardant, A. Adeye, A. Goundote, J. Saint-andre et al., Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study, The Lancet Global Health, vol.2, issue.7, pp.422-430, 2014.
DOI : 10.1016/S2214-109X(14)70223-2

, Dry-Reagent-Based qPCR and M. ulcerans Diagnosis

K. Asiedu, R. Sherpbier, and M. Raviglione, Buruli Ulcer Mycobacterium ulcerans infection, W.H.O. Global Buruli Ulcer initiative. Report World Health Organisation Geneva Switzerland, 2000.

P. Johnson, T. Stinear, P. Small, G. Pluschke, R. Merritt et al., Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control, PLoS Medicine, vol.43, issue.4, pp.108-15839744, 2005.
DOI : 10.1371/journal.pmed.0020108.g004

A. Chauty, M. Ardant, A. Adeye, H. Euverte, A. Guedenon et al., Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease), Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4029-4035, 2007.
DOI : 10.1128/AAC.00175-07

A. Chauty, M. Ardant, L. Marsollier, G. Pluschke, J. Landier et al., Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin, Clinical Infectious Diseases, vol.191, issue.1, pp.94-96, 2011.
DOI : 10.1517/14712590802631854
URL : https://academic.oup.com/cid/article-pdf/52/1/94/13802725/ciq072.pdf

F. Portaels, J. Agular, K. Fissette, P. Fonteyne, D. Beenhouwer et al., Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotidespecific capture plate hybridization, J Clin Microbiol, vol.35, pp.1097-1100, 1997.

S. Rondini, E. Mensah-quainoo, H. Troll, T. Bodmer, and G. Pluschke, Development and Application of Real-Time PCR Assay for Quantification of Mycobacterium ulcerans DNA, Journal of Clinical Microbiology, vol.41, issue.9, pp.4231-4237, 2003.
DOI : 10.1128/JCM.41.9.4231-4237.2003
URL : http://jcm.asm.org/content/41/9/4231.full.pdf

E. Marion, L. Ganlonon, E. Claco, S. Blanchard, M. Kempf et al., Establishment of Quantitative PCR (qPCR) and Culture Laboratory Facilities in a Field Hospital in Benin: 1-Year Results, Journal of Clinical Microbiology, vol.52, issue.12, pp.4398-4400, 2014.
DOI : 10.1128/JCM.02131-14

F. Portaels and W. , Laboratory diagnosis of buruli ulcer; A manual for health care providers Geneva: World Health Organization, p.105, 2014.

, Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease), WorldHealthOrganization, 2013.

V. Siegmund, O. Adjei, J. Nitschke, W. Thompson, E. Klutse et al., Dry Reagent-Based Polymerase Chain Reaction Compared with Other Laboratory Methods Available for the Diagnosis of Buruli Ulcer Disease, Clinical Infectious Diseases, vol.73, issue.6, pp.68-75, 2007.
DOI : 10.1128/IAI.73.6.3307-3312.2005

V. Siegmund, O. Adjei, P. Racz, C. Berberich, E. Klutse et al., Dry-Reagent-Based PCR as a Novel Tool for Laboratory Confirmation of Clinically Diagnosed Mycobacterium ulcerans-Associated Disease in Areas in the Tropics Where M. ulcerans Is Endemic, Journal of Clinical Microbiology, vol.43, issue.1, pp.271-276, 2005.
DOI : 10.1128/JCM.43.1.271-276.2005

S. Rondini, E. Mensah-quainoo, T. Junghanss, and G. Pluschke, What Does Detection of Mycobacterium ulcerans DNA in the Margin of an Excised Buruli Ulcer Lesion Tell Us?, Journal of Clinical Microbiology, vol.44, issue.11, pp.4273-4275, 2006.
DOI : 10.1128/JCM.00970-06

V. Cassisa, A. Chauty, E. Marion, M. Ardant, S. Eyangoh et al., Use of Fine-Needle Aspiration for Diagnosis of Mycobacterium ulcerans Infection, Journal of Clinical Microbiology, vol.48, issue.6, pp.2263-2264, 2010.
DOI : 10.1128/JCM.00558-10

E. Marion, S. Eyangoh, E. Yeramian, J. Doannio, J. Landier et al., Seasonal and Regional Dynamics of M. ulcerans Transmission in Environmental Context: Deciphering the Role of Water Bugs as Hosts and Vectors, PLoS Neglected Tropical Diseases, vol.4, issue.22, p.20625552, 2010.
DOI : 10.1371/journal.pntd.0000731.s001
URL : https://hal.archives-ouvertes.fr/inserm-00691396

, Treatment of Mycobacterium ulcerans (Buruli ulcer): Guidance for health workers, WorldHealthOrganization Geneva, vol.73, 2012.

S. Etuaful, B. Carbonnelle, J. Grosset, S. Lucas, C. Horsfield et al., Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3182-3186, 2005.
DOI : 10.1128/AAC.49.8.3182-3186.2005